Results 51 to 60 of about 20,430,225 (174)
Evolving Treatment Paradigms in Non-clear Cell Kidney Cancer [PDF]
Current Treatment Options in Oncology, 2018 With no therapy specifically approved for non-clear cell cancers of the kidney, this disease remains an orphan site. Clear cell renal cancers (ccRCC) have seen a flurry of activity with multiple agents gaining Food and Drug Administration (FDA) approval in recent years.
openaire +2 more sources
Clear Creek Consolidated Independent School District assessed value letters with handwritten notes
, 2019 Letters announcing a complete study of all assessed values of the Clear Creek Consolidated Independent School District completed by Pritchard and Abbott, valuation engineers of Houston, Texas.
core +1 more source
Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
Oncology Reviews, 2011 The treatment of metastatic renal cell carcinoma (RCC) has changed dramatically with the introduction of targeted therapies including sunitinib, sorafenib, and temsirolimus.
Daniel Y.C. Heng, Ronald M. Bukowski
doaj +2 more sources
Frontiers in Oncology, 2015 Much progress has been made in the treatment of metastatic renal cell carcinoma (RCC) over the last decade, with the development of agents that block the vascular endothelial growth factor (VEGF) pathway or the mammalian target of rapamycin (mTOR ...
Alexander eSankin +3 more
doaj +1 more source
BMC Urology, 2018 Background BRAF-activated long non-coding RNA (BANCR) has been associated with various types of cancer. Nevertheless, the role of BANCR in clear cell renal cell carcinoma (ccRCC) is still not fully understood.
Sheng Xue +9 more
doaj +1 more source
International Journal of General Medicine, 2022 Xuebao Xiang, Yi Guo, Zhongyuan Chen, Zengnan Mo Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical ...
Xiang X, Guo Y, Chen Z, Mo Z
doaj
Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma
Journal of Kidney Cancer and VHL, 2018 The purpose of this study was to assess the prognostic value of programmed death ligand-1 (PD-L1) positivity in a non-clear cell renal cell carcinoma (non-ccRCC) cohort.
Juan Chipollini +5 more
doaj +1 more source
Expression of insulin-like growth factor family genes in clear cell renal cell carcinoma
, 2016 Aim of the study : Despite significant progress in the pathology of clear cell renal cell carcinoma (ccRCC), diagnostic and predictive factors of major importance have not been discovered. Some hopes are associated with insulin-like growth factors.
Urszula Mazurek +4 more
core +1 more source
The Clear Lake Area. Where your future is beginning [PDF]
, 2016 Promotional booklet for the Clear Lake Area containing information about living, jobs, and ...
core +1 more source
Primary Renal Carcinoid Tumor Mimicking Non-Clear Cell Renal Cell Carcinoma: A Case Report
대한영상의학회지, 2016 Carcinoid tumors are neoplasms with neuroendocrine differentiation, and they are most commonly found in the gastrointestinal and respiratory systems. Primary renal carcinoid tumor has rarely been reported.
Leehi Joo +3 more
doaj +1 more source